Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial JE Cortes, DW Kim, HM Kantarjian, TH Brümmendorf, I Dyagil, ... Journal of Clinical Oncology 30 (28), 3486-3492, 2012 | 567 | 2012 |
The growing burden of cancer in India: epidemiology and social context MK Mallath, DG Taylor, RA Badwe, GK Rath, V Shanta, CS Pramesh, ... The Lancet Oncology 15 (6), e205-e212, 2014 | 476 | 2014 |
Delivery of affordable and equitable cancer care in India CS Pramesh, RA Badwe, BB Borthakur, M Chandra, EH Raj, T Kannan, ... The Lancet Oncology 15 (6), e223-e233, 2014 | 230 | 2014 |
Contralateral transradial approach for carotid artery stenting: a feasibility study T Patel, S Shah, A Ranjan, H Malhotra, S Pancholy, J Coppola Catheterization and Cardiovascular Interventions 75 (2), 268-275, 2010 | 116 | 2010 |
Pressor effects of alcohol in normotensive and hypertensive subjects H Malhotra, D Mathur, SR Mehta, PD Khandelwal The Lancet 326 (8455), 584-586, 1985 | 92 | 1985 |
Biosimilars and non-innovator biotherapeutics in India: an overview of the current situation H Malhotra Biologicals 39 (5), 321-324, 2011 | 46 | 2011 |
Gonadal function in prepubertal boys following treatment for Hodgkin's disease BN Dhabhar, H Malhotra, R Joseph, S Garde, S Bhasin, A Sheth, ... Journal of Pediatric Hematology/Oncology 15 (3), 306-310, 1993 | 45 | 1993 |
An ongoing phase 3 study of bosutinib (SKI-606) versus imatinib in patients with newly diagnosed chronic phase chronic myeloid leukemia C Gambacorti-Passerini, DW Kim, HM Kantarjian, TH Brummendorf, ... Blood 116 (21), 208, 2010 | 43 | 2010 |
Phase I chemotherapy study of biochemical modulation of folinic acid and fluorouracil by gemcitabine in patients with solid tumor malignancies S Madajewicz, P Hentschel, P Burns, R Caruso, J Fiore, M Fried, ... Journal of clinical oncology 18 (20), 3553-3557, 2000 | 41 | 2000 |
Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia MB Agarwal, H Malhotra, P Chakrabarti, N Varma, V Mathews, ... Indian journal of medical and paediatric oncology 36 (01), 3-16, 2015 | 40 | 2015 |
Global regulatory landscape of biosimilars: emerging and established market perspectives A Krishnan, R Mody, H Malhotra Biosimilars, 19-32, 2015 | 37 | 2015 |
Reversal of tamoxifen resistance (hormone resistance) by addition of sirolimus (mTOR inhibitor) in metastatic breast cancer GS Bhattacharvva, J Biswas, JK Singh, M Singh, K Govindbabu, ... European journal of cancer, 9, 2011 | 37 | 2011 |
41LBA Single institute phase II study of weekly cisplatinum and metronomic dosing of endoxan and methotrexate in second line metastatic breast cancer triple-negative GS Bhattacharyya, S Basu, V Agarwal, H Malhotra, PM Pareekh, KG Babu, ... EJC Supplements 3 (7), 18-19, 2009 | 37 | 2009 |
Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II study KG Babu, K Prabhash, AK Vaid, B Sirohi, RB Diwakar, R Rao, M Kar, ... OncoTargets and therapy, 1051-1060, 2014 | 32 | 2014 |
Hepatocellular carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up P Parikh, H Malhotra, S Jelic Annals of oncology 19, ii27-ii28, 2008 | 29 | 2008 |
Correlation of plasma trough levels of imatinib with molecular response in patients with chronic myeloid leukemia H Malhotra, P Sharma, S Bhargava, OS Rathore, B Malhotra, M Kumar Leukemia & lymphoma 55 (11), 2614-2619, 2014 | 24 | 2014 |
T‐lymphoid blast crisis in chronic myeloid leukemia SH Advani, H Malhotra, PR Kadam, RS Iyer, G Nanjangud, B Balsara, ... American journal of hematology 36 (2), 86-92, 1991 | 24 | 1991 |
Effect of coadministered beta blocker and COX-2 inhibitor to patients with pancreatic cancer prior to receiving albumin-bound (Nab) paclitaxel. GS Bhattacharyya, KG Babu, SA Bondarde, G Biswas, A Ranade, ... Journal of Clinical Oncology 33 (3_suppl), 302-302, 2015 | 21 | 2015 |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer R Kanesvaran, E Castro, A Wong, K Fizazi, MLK Chua, Y Zhu, H Malhotra, ... ESMO open 7 (4), 100518, 2022 | 20 | 2022 |
Indian Council of Medical Research consensus document for the management of buccal mucosa cancer GK Rath, PM Parikh, S Hukku, B Rajan, S Kumar, H Malhotra, S Vuthaluru, ... Indian Journal of Medical and Paediatric Oncology 35 (02), 136-139, 2014 | 20 | 2014 |